On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< GBT Global Blood Therapeutics - 06:49 Today
- Pfizer to acquire Global Blood Therapeutics for $68.50 per share in cash
- 06:46 Today
- Pfizer to acquire Global Blood Therapeutics for $68.50 per share in cash
- 08/05/22
- Global Blood Therapeutics trading resumes
- 08/05/22
- Fulcrum Therapeutics up 8% after WSJ says Pfizer in talks to buy Global Blood
- 06:49 Today
- Pfizer to acquire Global Blood Therapeutics for $68.50 per share in cash
- 06:46 Today
- Pfizer to acquire Global Blood Therapeutics for $68.50 per share in cash
- 08/07/22
- Myovant Sciences, Pfizer receive FDA approval of MYFEMBREE
- 08/05/22
- Fulcrum Therapeutics up 8% after WSJ says Pfizer in talks to buy Global Blood
- $173.92 /
-16.02 (-8.43%) - 09:23 Today
- Nvidia falls 6.9% to $176.74 after negative Q2 revenue pre-announcement
- 07/20/22
- Motorsport Games brings two titles to NVIDIA GeForce NOWNvidia
- 07/15/22
- U.S. video game spending falls 11% y/y in June, says NPD
- 07/12/22
- Nvidia announces hybrid quantum-classical computing platform
- 05:46 Today
- Carlyle Group CEO Kewsong Lee to step down, Bill Conway to be interim CEO
- 07/12/22
- Madison Dearborn Partners to acquire majority stake in Unison from Carlyle
- 05/16/22
- Carlyle to acquire ManTech for $96 per share in $4.2B enterprise value deal
- 05/09/22
- White Mountains to sell NSM Insurance Group to Carlyle Group
- $905.20 /
+40.72 (+4.71%) - 08/07/22
- Elon Musk challenges Twitter CEO to 'a public debate' on bots
- 08/07/22
- Musk says Twitter deal should not proceed if SEC filings 'materially false'
- 08/05/22
- Tesla confirms three-for-one stock split
- 08/03/22
- American Battery Metals appoints Belanger as Staff Analytical Chemist
- 08/07/22
- Elon Musk challenges Twitter CEO to 'a public debate' on bots
- 08/07/22
- Musk says Twitter deal should not proceed if SEC filings 'materially false'
- 08/05/22
- Twitter rejects Elon Musk's claims that he was 'hoodwinked'
- 08/05/22
- Twitter Chairman says Musk's claims 'factually inaccurate'
- 07:09 Today
- Whirlpool confirms pact with Emerson Electric to acquire InSinkErator for $3B
- 06:56 Today
- Emerson Electric to sell InSinkErator business to Whirlpool for $3B
- 06:55 Today
- Emerson Electric to sell InSinkErator business to Whirlpool for $3B
- 07/27/22
- Emerson unit AspenTech to acquire Micromine, no terms
- 07:09 Today
- Whirlpool confirms pact with Emerson Electric to acquire InSinkErator for $3B
- 06:56 Today
- Emerson Electric to sell InSinkErator business to Whirlpool for $3B
- 06:55 Today
- Emerson Electric to sell InSinkErator business to Whirlpool for $3B
- 07/26/22
- Winnebago appoints Casey Tubman as Newmar president
- 07/28/22
- First Solar to supply 2.4 GW of PV solar modules to Intersect Power
- 07/26/22
- First Solar issues 2022 Sustainability Report
- 07/25/22
- First Solar announces Akuo placed order for 500MW of thin film PV solar modules
- 07/21/22
- First Solar to supply Solarvest Holdings with 93 MW for Malaysian projects
- 05/23/22
- TPI Composites appoints Miller as CFO
- 05/19/22
- TPI Composites approves changes to corporate governance policies
- 02/25/22
- TPI Composites trading resumes
- 02/25/22
- TPI Composites trading halted, volatility trading pause
- 08/03/22
- Paramount+ to launch as a Premium Subscription within Roku Channel
- 07/28/22
- Roku drops 25% to $63.40 after Q2 results, Q3 guidance miss estimates
- 07/26/22
- Cathie Wood's ARK Investment bought 585K shares of Roku today
- 06/23/22
- Crackle launches updated app on Roku devices
WBD Warner Bros. Discovery - 08/04/22
- Warner Bros. Discovery backs long-term leverage target of 2.5-3.0
- 08/04/22
- Warner Bros. Discovery sees FY23 adjusted EBITDA of 'at least $12B'
- 08/04/22
- AT&T, Warner Bros. Discovery announces distribution pact for HBO Max
- 08/04/22
- Warner Bros. Discovery launches dedicated CNN Originals hub on discovery+
- 08/05/22
- Western Digital drops 8% to $45.80 after Q1 guidance misses estimates
- 07/21/22
- Western Digital, Micron trade lower after Seagate earnings miss
- 07/21/22
- Seagate drops 11% to $74.05 after results miss estimates
- 06/08/22
- Western Digital jumps 3.7% after announcing review to split Flash and HDD units
- 08/07/22
- Fly Intel: Top five weekend stock stories
- 08/04/22
- CDW appoints Carolyn Wiesenhahn as CPO
- 08/03/22
- CVS Health says liquidity, cash position 'remain excellent'
- 08/03/22
- CVS Health says posted strong results across all business segments in Q2
- $22.80 /
+2.935 (+14.77%) - 12:00 Today
- Signify Health rises 14.5%
- 09:47 Today
- Signify Health rises 15.9%
- 08/07/22
- Fly Intel: Top five weekend stock stories
- 08/03/22
- Signify Health sees FY HCS revenue $800M-$810M
- 08/03/22
- Microsoft says Teams now optimized for Mac computers
- 07/28/22
- Apple says 'constantly surveilling' the market for potential acquisitions
- 07/28/22
- Apple expects Q4 revenue to accelerate y/y
- 07/28/22
- Apple says response to iPhone 13 'continues to be strong'
- 08/02/22
- Mandiant to not provide guidance due to pending transaction with Google
- 08/02/22
- Thryv and Google team to streamline communication for small businesses
- 07/31/22
- Fly Intel: Top five weekend stock stories
- 07/29/22
- Google says Stadia game streaming service not shutting down
- 08/02/22
- Mandiant to not provide guidance due to pending transaction with Google
- 07/31/22
- Fly Intel: Top five weekend stock stories
- 07/29/22
- Google says Stadia game streaming service not shutting down
- 07/28/22
- Google updates Play Store policies around intrusive advertisements
- 05/16/22
- David Einhorn's Greenlight adds Southwestern, exits Sonos in Q1
- 05/11/22
- Sonos introduces Sonos Voice Control
- 04/11/22
- Sonos acquiures 'audio transducers' firm Mayht for $100M to enhance portfolio
- 03/30/22
- Sonos to replace Chart Industries in S&P 600 at open on 3/30
- 08/04/22
- Coinbase trading resumes
- 08/04/22
- Coinbase trading halted, volatility trading pause
- 08/04/22
- Coinbase jumps 34% to $108.46 after announcing partnership with BlackRock
- 08/04/22
- Coinbase selected by BlackRock for crypto trading access
- $235.28 /
+95.17 (+67.93%) - 07:35 Today
- Zai Lab partner Karuna announces results from Phase 3 EMERGENT-2 trial
- 06:40 Today
- Karuna Therapeutics says Phase 3 EMERGENT-2 trial met primary endpoint
- $35.98 /
+12.48 (+53.11%) - 07:24 Today
- CinCor Pharma announces data for Phase 2 BrigHtn trial evaluating baxdrostat
- 07:21 Today
- CinCor Pharma announces upcoming milestones
- 07/26/22
- CinCor Pharma announces last patient randomized in Phase 2 HALO trial
- 06/01/22
- CinCor Pharma doses first patient in Phase 2 figHTN-CKD trial
- 12:00 Today
- W&T Offshore rises 18.5%
- 07:22 Today
- W&T Offshore sees 2022 total equivalents 14,450-15,450 MBoe
- 07:21 Today
- W&T Offshore sees Q3 total equivalents 3,550-4,050 MBoe
- 07:21 Today
- W&T Offshore sees 2022 average daily equivalents 39.5-42 MBoe/d
RETA Reata Pharmaceuticals - $24.10 /
-11.815 (-32.90%) - 09:41 Today
- Reata Pharmaceuticals trading resumes
- 09:36 Today
- Reata Pharmaceuticals trading halted, volatility trading pause
- 05/26/22
- Reata Pharmaceuticals' NDA for omaveloxolone granted Priority Review by FDA
- 03/31/22
- Reata Pharmaceuticals completes rolling submission for omaveloxolone NDA
- 06/23/22
- uniQure provides update on low-dose cohort in Phase I/II trial of AMT-130
- 06/22/22
- uniQure announces grant equity awards to 32 new employees
- 05/24/22
- uniQure announces FDA accepts priority review BLA for etranacogene dezaparvovec
- 05/11/22
- uniQure announces inducement grants under Nasdaq listing rule 5635(c)(4)
- $10.12 /
-1.325 (-11.58%) - 12:01 Today
- Palantir falls -12.0%
- 10:00 Today
- Palantir falls -14.4%
- 09:47 Today
- Palantir falls -12.2%
- 07/28/22
- Palantir announces $99.9M contract with U.S. Army Research Laboratory
- 09:39 Today
- Tyson Foods: Demand for chicken 'extremely strong'
- 09:39 Today
- Tyson: Prepared fods unit can't fulfill all orders due to supply constraints
- 09:10 Today
- Tyson Foods CEO says demand 'relatively steady'
- 09:08 Today
- Tyson Foods focused on overcoming supply chain challenges, says CEO
- 06:08 Today
- BioNTech backs FY22 CapEx view EUR 450M- EUR 550M
- 08/05/22
- BioNTech, Genmab expand immunotherapies collaboration
- 07/27/22
- BioNTech, Pfizer to study enhanced COVID-19 mRNA-based vaccine candidate
- 07/19/22
- Pfizer, BioNTech complete submission to EMA for Omicron BA.1 adapted vaccine
- 05/13/22
- Soros buys Lucid, exits GM in Q1
- 04/27/22
- Elanco secures exclusive U.S. license for Bovaer production
- 04/12/22
- Elanco unveils plans for global headquarters in Indianapolis
- 04/11/22
- Elanco, Ginkgo Bioworks launch BiomEdit, a microbiome innovation company
- 04/20/22
- Stericycle confirms anti-corruption resolutions with DOJ, SEC
- 04/20/22
- Stericycle charged by SEC with bribery schemes in Latin America
- 02/24/22
- Stericycle sees five-year CAGR of 3%-5%
GBT Global Blood Therapeutics - 11:52 Today Truist
- Global Blood Therapeutics downgraded to Hold from Buy at Truist
- 11:28 Today Stifel
- Global Blood Therapeutics downgraded to Hold from Buy at Stifel
- 10:02 Today William Blair
- Global Blood Therapeutics downgraded to Market Perform from Outperform at William Blair
- 09:28 Today Jefferies
- Global Blood Therapeutics downgraded to Hold from Buy at Jefferies
- 11:28 Today Stifel
- Global Blood Therapeutics downgraded to Hold from Buy at Stifel
- 08:24 Today Piper Sandler
- Global Blood takeover by Pfizer 'solid outcome,' says Piper Sandler
- 08:19 Today Wedbush
- Wedbush downgrades Biohaven to Neutral, sees Pfizer acquisition on track
- 07:38 Today Canaccord
- Canaccord upgraded Global Blood to Buy before Pfizer takeover news
- $173.92 /
-16.02 (-8.43%) - 10:12 Today Piper Sandler
- Piper not surprised by Nvidia's gaming decline, but surprised by size of miss
- 07/25/22 Barclays
- Nvidia price target lowered to $200 from $295 at Barclays
- 07/20/22 Deutsche Bank
- Nvidia price target lowered to $175 from $190 at Deutsche Bank
- 07/15/22 Goldman Sachs
- Nvidia price target lowered to $166 from $192 at Goldman Sachs
- 07/29/22 Evercore ISI
- Carlyle Group upgraded to Outperform from In Line at Evercore ISI
- 07/13/22 Deutsche Bank
- Carlyle Group price target lowered to $56 from $64 at Deutsche Bank
- 06/08/22 JMP Securities
- Carlyle Group initiated with an Outperform at JMP Securities
- 05/19/22 Deutsche Bank
- Carlyle Group price target lowered to $64 from $68 at Deutsche Bank
- $905.20 /
+40.72 (+4.71%) - 07:44 Today Canaccord
- Tesla price target raised to $881 from $815 at Canaccord
- 08/05/22 Susquehanna
- Susquehanna downgrades Twitter on 'uncertainty and disruption' from takeover
- 08/03/22 Morgan Stanley
- Tesla exposed to both risk and opportunity of battery race, says Morgan Stanley
- 08/02/22 Citi
- Tesla price target raised to $424 from $375 at Citi
- 08/05/22 Susquehanna
- Susquehanna downgrades Twitter on 'uncertainty and disruption' from takeover
- 08/05/22 Susquehanna
- Twitter downgraded to Neutral from Positive at Susquehanna
- 07/27/22 Jefferies
- Alphabet price target lowered to $130 from $155 at Jefferies
- 07/25/22 Cowen
- Twitter price target lowered to $22 from $38 at Cowen
- 07/18/22 Mizuho
- Emerson Electric price target lowered to $85 from $100 at Mizuho
- 07/13/22 Deutsche Bank
- Emerson Electric price target lowered to $97 from $110 at Deutsche Bank
- 07/12/22 Wells Fargo
- Emerson Electric price target raised to $89 from $87 at Wells Fargo
- 07/08/22 Barclays
- Emerson Electric price target lowered to $80 from $87 at Barclays
- 07/15/22 JPMorgan
- Whirlpool price target lowered to $191 from $227 at JPMorgan
- 04/20/22 JPMorgan
- Whirlpool price target lowered to $205 from $221 at JPMorgan
- 04/05/22 Credit Suisse
- Whirlpool initiated with a Neutral at Credit Suisse
- 03/30/22 JPMorgan
- Whirlpool price target lowered to $221 from $295 at JPMorgan
- 07:13 Today JPMorgan
- First Solar upgraded to Overweight from Neutral at JPMorgan
- 07:08 Today Guggenheim
- First Solar upgraded to Buy at Guggenheim on confidence in passage of IRA act
- 06:23 Today Guggenheim
- First Solar upgraded to Buy from Neutral at Guggenheim
- 08/05/22 Argus
- First Solar price target raised to $123 from $104 at Argus
- 07:13 Today JPMorgan
- TPI Composites upgraded to Overweight from Neutral at JPMorgan
- 08/04/22 Cowen
- TPI Composites price target raised to $20 from $15 at Cowen
- 07/19/22 Piper Sandler
- TPI Composites price target lowered to $12 from $14 at Piper Sandler
- 05/06/22 Roth Capital
- TPI Composites upgraded to Buy from Neutral at Roth Capital
- 05:07 Today Pivotal Research
- Roku downgraded to Sell from Hold at Pivotal Research
- 08/03/22 Citi
- Roku price target lowered to $125 from $165 at Citi
- 08/01/22 Morgan Stanley
- Roku price target lowered to $55 from $80 at Morgan Stanley
- 07/29/22 BofA
- BofA double downgrades Roku with headwinds seen lasting 2-3 quarters
WBD Warner Bros. Discovery - 09:00 Today Barrington
- Warner Bros. Discovery downgraded to Market Perform from Outperform at Barrington
- 08/05/22 Wells Fargo
- Warner Bros. Discovery downgraded to Equal Weight at Wells Fargo
- 08/05/22 Barclays
- Warner Bros. Discovery price target lowered to $17 from $19 at Barclays
- 08/04/22 Credit Suisse
- Warner Bros. Discovery price target lowered to $43 from $52 at Credit Suisse
- 08:31 Today Craig-Hallum
- Western Digital price target lowered to $85 from $90 at Craig-Hallum
- 07:58 Today Deutsche Bank
- Western Digital price target lowered to $56 from $64 at Deutsche Bank
- 07:11 Today Benchmark
- Western Digital downgraded to Hold at Benchmark amid sharp inventory correction
- 07:11 Today Baird
- Western Digital price target lowered to $55 from $75 at Baird
- 07:02 Today BofA
- CVS deal for Signify would help with continued evolution, says BofA
- 08/04/22 Evercore ISI
- CVS Health removed from 'TAP Outperform' list at Evercore ISI
- 08/04/22 Deutsche Bank
- CVS Health price target raised to $120 from $113 at Deutsche Bank
- 07/21/22 Stifel
- Logical to see Oak Street, Cano as 'in play' after 1Life deal, says Stifel
- $22.80 /
+2.935 (+14.77%) - 07:37 Today Cowen
- Signify Health price target raised to $24 from $14 at Cowen
- 07:02 Today BofA
- CVS deal for Signify would help with continued evolution, says BofA
- 08/04/22 Piper Sandler
- Signify Health price target raised to $34 from $32 at Piper Sandler
- 07/28/22 RBC Capital
- Signify Health initiated with a Sector Perform at RBC Capital
- 09:27 Today B. Riley
- B. Riley thinks Globalstar's mystery satellite capacity customer is Apple
- 08/05/22 BMO Capital
- Skyworks price target raised to $135 from $120 at BMO Capital
- 08/05/22 Needham
- Meta Platforms outlook made worse by Apple's AdTech platform, says Needham
- 08/03/22 Morgan Stanley
- Apple App Store growth decelerated in July, says Morgan Stanley
- 08/03/22 Tigress Financial
- Alphabet price target raised to $186 from $183 at Tigress Financial
- 07/27/22 Truist
- Chrome cookie phase-out delay positive for Criteo, says Truist
- 07/27/22 KeyBanc
- Google's cookie phase-out delay not surprising, says KeyBanc
- 07/27/22 RBC Capital
- Google cookie phase-out delay adds another year of uncertainty, says RBC Capital
- 08/03/22 Tigress Financial
- Alphabet price target raised to $186 from $183 at Tigress Financial
- 07/27/22 Truist
- Chrome cookie phase-out delay positive for Criteo, says Truist
- 07/27/22 KeyBanc
- Google's cookie phase-out delay not surprising, says KeyBanc
- 07/27/22 RBC Capital
- Google cookie phase-out delay adds another year of uncertainty, says RBC Capital
- 06/14/22 Morgan Stanley
- Sonos downgraded to Equal Weight at Morgan Stanley amid inflation pressures
- 06/14/22 Morgan Stanley
- Sonos downgraded to Equal Weight from Overweight at Morgan Stanley
- 05/31/22 Jefferies
- Sonos price target lowered to $35 from $45 at Jefferies
- 05/12/22 DA Davidson
- Sonos price target lowered to $40 from $49 at DA Davidson
- 06:55 Today Daiwa
- Coinbase downgraded to Outperform from Buy at Daiwa
- 08/05/22 Citi
- Citi cuts Coinbase target but opens 'upside Catalyst Watch'
- 08/04/22 JMP Securities
- JMP 'encouraged' by Coinbase partnership with BlackRock's Aladdin
- 08/04/22 Mizuho
- Coinbase shares jumped 20% 'for no good reason,' says Mizuho
- $235.28 /
+95.17 (+67.93%) - 07/14/22 SVB Securities
- SVB starts 'late-stage story' Karuna with Outperform, $170 target
- 07/14/22 SVB Securities
- Karuna Therapeutics initiated with an Outperform at SVB Securities
- 06/28/22 JMP Securities
- Karuna Therapeutics price target raised to $190 from $175 at JMP Securities
- 04/27/22 Mizuho
- Karuna Therapeutics price target raised to $190 from $178 at Mizuho
- $35.98 /
+12.48 (+53.11%) - 07/21/22 Oppenheimer
- CinCor Pharma price target raised to $35 from $30 at Oppenheimer
- 02/01/22 Oppenheimer
- CinCor Pharma initiated with an Outperform at Oppenheimer
- 02/01/22 Evercore ISI
- CinCor Pharma initiated with an Outperform at Evercore ISI
- 02/01/22 Jefferies
- CinCor Pharma initiated with a Buy at Jefferies
- 07/27/22 Stifel
- Stifel keeps Buy on W&T Offshore, raises price target to $8.40
- 10/20/21 Stifel
- W&T Offshore upgraded to Buy at Stifel on improving prices
- 10/20/21 Stifel
- W&T Offshore upgraded to Buy from Hold at Stifel
- 09/09/21 Roth Capital
- W&T Offshore should be bought on any weakness, says Roth Capital
RETA Reata Pharmaceuticals - $24.10 /
-11.815 (-32.90%) - 05/27/22 Citi
- Reata Pharmaceuticals price target raised to $46 from $43 at Citi
- 05/11/22 Ladenburg
- Reata Pharmaceuticals price target lowered to $67 from $75 at Ladenburg
- 05/10/22 Goldman Sachs
- Goldman ups target for Reata to $93, remains confident in approval
- 03/28/22 Jefferies
- Reata drop on Amylyx docs an opportunity to accumulate shares, says Jefferies
- 12:05 Today Truist
- uniQure's high-dose HD data still on track for 1H23, says Truist
- 05/05/22 Stifel
- uniQure price target lowered to $37 from $66 at Stifel
- 04/13/22 Truist
- uniQure price target lowered to $51 from $90 at Truist
- 03/30/22 Chardan
- uniQure price target lowered to $65 from $95 at Chardan
- $10.12 /
-1.325 (-11.58%) - 08/03/22 RBC Capital
- U.S. federal spending tracker 'worrisome' for Palantir, says RBC Capital
- 07/22/22 Monness Crespi
- Monness downgrades Palantir, says recent rally may be unsustainable
- 07/22/22 Monness Crespi
- Palantir downgraded to Neutral from Buy at Monness Crespi
- 07/21/22 Raymond James
- Raymond James starts Palantir with Strong Buy, sees shares doubling
- 07/20/22 Cleveland Research
- Tyson Foods downgraded to Neutral from Buy at Cleveland Research
- 07/01/22 Piper Sandler
- Tyson Foods price target lowered to $79 from $85 at Piper Sandler
- 05/03/22 Piper Sandler
- Tyson Foods downgraded to Underweight from Neutral at Piper Sandler
- 03/14/22 BMO Capital
- Tyson Foods downgraded to Market Perform from Outperform at BMO Capital
- 07/13/22 SVB Securities
- BioNTech upgraded to Outperform from Market Perform at SVB Securities
- 07/11/22 H.C. Wainwright
- BioNTech price target lowered to $283 from $298 at H.C. Wainwright
- 07/06/22 Canaccord
- BioNTech assumed with a Buy at Canaccord
- 06/13/22 Morgan Stanley
- Moderna pediatric EUA vaccine briefing docs 'clean,' says Morgan Stanley
- 07/21/22 Goldman Sachs
- Elanco downgraded to Sell from Buy at Goldman Sachs
- 07/18/22 Cowen
- Cowen believes Global Pharma quarterly results will be strong
- 07/18/22 JPMorgan
- JPMorgan cuts Elanco target, Zoetis remains top animal health idea
- 07/11/22 Piper Sandler
- Elanco initiated with a Neutral at Piper Sandler
- 09:42 Today RBC Capital
- Stericycle price target lowered to $70 from $82 at RBC Capital
- 05/12/22 Berenberg
- Stericycle downgraded on inflationary environment at Berenberg
- 05/12/22 Berenberg
- Stericycle downgraded to Hold from Buy at Berenberg
- 04/29/22 Baird
- Stericycle price target lowered to $63 from $72 at Baird
GBT Global Blood Therapeutics - 05/04/22
- Global Blood Therapeutics reports Q1 EPS ($1.26), consensus ($1.30)
- 02/24/22
- Global Blood Therapeutics reports Q4 EPS ($1.36), consensus ($1.13)
- 07/28/22
- Pfizer raises FY22 adjusted EPS view to $6.30-$6.45 from $6.25-$6.45
- 07/28/22
- Pfizer reports Q2 adjusted EPS $2.04, consensus $1.80
- 07/27/22
- Notable companies reporting before tomorrow's open
- 07/27/22
- Notable companies reporting before tomorrow's open
- $173.92 /
-16.02 (-8.43%) - 09:03 Today
- Nvidia reports preliminary Q2 revenue $6.7B, consensus $8.1B
- 05/25/22
- Nvidia sees Q2 revenue $8.1B, +/- 2%, consensus $8.45B
- 05/25/22
- Nvidia reports Q1 EPS $1.36, consensus $1.29
- 05/25/22
- Notable companies reporting after market close
- 04/29/22
- Carlyle Group reports Q1 EPS 74c vs. 58c last year
- $905.20 /
+40.72 (+4.71%) - 07/20/22
- Tesla reports Q2 EPS $2.27, consensus $1.85
- 07/20/22
- Notable companies reporting after market close
- 04/20/22
- Tesla reports Q1 EPS $3.22, consensus $2.26
- 04/20/22
- Notable companies reporting after market close
- 07/22/22
- Twitter reports Q2 EPS (8c), consensus 14c
- 07/21/22
- Notable companies reporting before tomorrow's open
- 07/21/22
- Notable companies reporting before tomorrow's open
- 04/28/22
- Twitter withdrawing previously provided outlook given pending acquisition
- 05/04/22
- Emerson Electric sees Q3 adjusted EPS $1.25-$1.30, consensus $1.33
- 05/04/22
- Emerson Electric raises FY22 adjusted EPS view to $4.95-$5.10 from $4.90-$5.05
- 05/04/22
- Emerson Electric reports Q2 adjusted EPS $1.29, consensus $1.18
- 07/25/22
- Whirlpool reports Q2 revenue, ex-currency, $5.2B, consensus $5.23B
- 07/25/22
- Whirlpool cuts FY22 adjusted EPS view to $22.00-$24.00 from $24.00-$26.00
- 07/25/22
- Whirlpool cuts FY22 revenue growth view to (6%) from 2%-3%, consensus $21.84B
- 07/25/22
- Whirlpool cuts FY22 cash from operating activities view to $1.85B from $1.95B
- 07/28/22
- First Solar lowers FY22 EPS guidance to (25c)-25c from 0c-60c, consensus (4c)
- 07/28/22
- First Solar reports Q2 EPS 52c, consensus 23c
- 07/28/22
- Notable companies reporting after market close
- 04/28/22
- First Solar backs FY22 revenue view $2.4B-$2.6B, consensus $2.54B
- 08/03/22
- TPI Composites sees FY22 capital expenditures $15M-$20M down from $25M-$30M
- 08/03/22
- TPI Composites reports Q2 EPS (48c), consensus (41c)
- 05/05/22
- TPI Composites sees FY22 capital expenditures $25M-$30M
- 05/05/22
- TPI Composites reports Q1 EPS (71c), consensus (87c)
- 07/28/22
- Roku sees Q3 revenue roughly $700M, consensus $901.73M
- 07/28/22
- Roku reports Q2 EPS (82c), consensus (68c)
- 07/28/22
- Notable companies reporting after market close
- 04/28/22
- Roku backs FY22 revenue growth view of 35% y/y, consensus $3.72B
WBD Warner Bros. Discovery - 08/04/22
- Warner Bros. Discovery cuts FY22 adjusted EBITDA view to $9.0B-$9.5B
- 08/04/22
- Warner Bros. Discovery reports Q2 EPS with items ($1.50), consensus (3c)
- 08/04/22
- Notable companies reporting after market close
- 04/26/22
- Warner Bros. Discovery reports Q1 diluted EPS 69c vs. 21c a year ago
- 08/05/22
- Western Digital sees Q1 EPS 35c-65c, consensus $1.96
- 08/05/22
- Western Digital reports Q4 EPS $1.78, consensus $1.68
- 04/28/22
- Western Digital sees Q4 adjusted EPS $1.60-$1.90, consensus $1.69
- 04/28/22
- Western Digital reports Q3 adjusted EPS $1.65, consensus $1.42
- 08/03/22
- CVS Health raises FY22 revenue view to $307B-$312B from $305B-$310B
- 08/03/22
- CVS Health raises 2022 adjusted EPS view $8.40-$8.60 from $8.20-$8.40
- 08/03/22
- CVS Health reports Q2 adjusted EPS $2.40, consensus $2.17
- 08/02/22
- Notable companies reporting before tomorrow's open
- $22.80 /
+2.935 (+14.77%) - 08/03/22
- Signify Health reports Q2 EPS ($2.10), consensus 10c
- 05/04/22
- Signify Health reaffirms FY22 revenue view $948M-$971M, consensus $961.01M
- 05/04/22
- Signify Health reports Q1 EPS (6c), consensus 4c
- 03/02/22
- Signify Health sees FY22 revenue $948M-$971M, consensus $928.21M
- 07/28/22
- Apple reports Q3 EPS $1.20, consensus $1.16
- 07/28/22
- Notable companies reporting after market close
- 04/28/22
- Apple says y/y Q3 revenue growth to be impacted by COVID
- 04/28/22
- Apple reports Q2 EPS $1.52, consensus $1.43
- 07/26/22
- Alphabet reports Q2 EPS $1.21, consensus $1.30
- 07/26/22
- Notable companies reporting after market close
- 04/26/22
- Alphabet reports Q1 EPS $24.62, consensus $25.96
- 04/26/22
- Notable companies reporting after market close
- 07/26/22
- Alphabet reports Q2 EPS $1.21, consensus $1.30
- 07/26/22
- Notable companies reporting after market close
- 04/26/22
- Alphabet reports Q1 EPS $24.62, consensus $25.96
- 04/26/22
- Notable companies reporting after market close
- 05/11/22
- Sonos backs FY22 revenue view $1.95B-$2B, consensus $1.97B
- 05/11/22
- Sonos reports Q2 adjusted EPS 26c, consensus 7c
- 02/09/22
- Sonos raises FY24 revenue view to $2.5B, up 13% CAGR from FY22 view
- 02/09/22
- Sonos sees FY22 revenue $1.95B-$2.0B, consensus $1.95B
- 05/10/22
- Coinbase reports Q1 EPS ($1.98) vs. $3.80 last year
- 05/10/22
- Coinbase reports Q1 revenue $1.165B, consensus $1.48B
- 05/10/22
- Notable companies reporting after market close
- 02/24/22
- Coinbase reports Q4 adjusted EBITDA $1.21B vs. $288M y/y
- $235.28 /
+95.17 (+67.93%) - 06:38 Today
- Karuna Therapeutics reports Q2 EPS ($2.17), consensus ($2.09)
- 05/05/22
- Karuna Therapeutics reports Q1 EPS ($1.95), consensus ($2.11)
- 02/24/22
- Karuna Therapeutics reports Q4 EPS (94c), consensus ($1.73)
- $35.98 /
+12.48 (+53.11%) - 07:20 Today
- CinCor Pharma reports Q2 EPS (56c), consensus (50c)
- 05/10/22
- CinCor Pharma reports Q1 EPS (50c), consensus (50c)
- 03/22/22
- CinCor Pharma reports Q4 EPS ($15.71) vs. ($4.65) last year
- 07:19 Today
- W&T Offshore reports Q2 adjusted EPS $1.32 vs. 1c last year
- 03/08/22
- W&T Offshore reports Q4 adjusted EPS 10c, consensus 3c
RETA Reata Pharmaceuticals - $24.10 /
-11.815 (-32.90%) - 06:49 Today
- Reata Pharmaceuticals reports Q2 non/GAAP EPS $1.36, consensus
- 05/10/22
- Reata Pharmaceuticals reports Q1 adjusted EPS ($1.33), consensus ($2.15)
- 02/28/22
- Reata Pharmaceuticals reports Q4 EPS ($2.35), consensus ($2.31)
- 07:16 Today
- uniQure reports Q2 EPS (84c) vs $8.51 last year
- 05/02/22
- uniQure reports Q1 EPS ($1.00), consensus (93c)
- 02/25/22
- uniQure reports 2021 EPS $7.04, consensus $6.20
- $10.12 /
-1.325 (-11.58%) - 07:09 Today
- Palantir sees FY22 revenue $1.9B - $1.902B , consensus $1.96B
- 07:08 Today
- Palantir sees Q3 revenue $474M - $475M , consensus $506.88M
- 07:06 Today
- Palantir reports Q2 EPS (9c) vs. (7c) last year
- 05/09/22
- Palantir sees Q2 revenue base case $470M, consensus $483.84M
- 07:06 Today
- Tyson Foods sees 2022 revenue $52B-$54B, consensus $52.8B
- 07:03 Today
- Tyson Foods reports Q3 adjusted EPS $1.94 vs. $2.70 last year
- 07/06/22
- Tyson Foods buys strategic stake in Tanmiah of Saudi Arabia
- 05/09/22
- Tyson Foods raises FY22 revenue view to $52B-$54B from $49B-$51B
- 06:02 Today
- BioNTech backs FY22 COVID-19 vaccine revenue view EUR 13B-EUR 17B
- 06:01 Today
- BioNTech reports Q2 EPS EUR 6.45 vs. EUR 10.77 last year
- 05/09/22
- BioNTech reports Q1 EPS EUR 14.24 vs. EUR 4.39 last year
- 03/30/22
- BioNTech reports Q4 EPS EUR 12.18 vs. EUR 1.43 last year
- 06:36 Today
- Elanco sees Q3 adjusted EPS 12c-18c, consensus 26c
- 06:34 Today
- Elanco lowers 2022 adjusted EPS view to $1.06-$1.13 from $1.15-$1.21
- 06:32 Today
- Elanco reports Q2 adjusted EPS 36c, consensus 25c
- 05/09/22
- Elanco cuts FY22 adjusted EPS view to $1.15-$1.21 from $1.18-$1.24
- 09:40 Today
- Stericycle narrows FY22 EPS view to $2.00-$2.15 from $2.00-$2.30
- 08/05/22
- Stericycle reports Q2 adjusted EPS 48c vs 67c last year
- 04/28/22
- Stericycle reports Q1 adjusted EPS 32c, consensus 46c
- 02/24/22
- Stericycle sees FY22 adjusted EPS $2.00-$2.30, consensus $2.32
|